Skip to main content

Advertisement

Log in

Becker muscular dystrophy: case report, review of the literature, and analysis of differentially expressed hub genes

  • Review Article
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract

Introduction

Becker muscular dystrophy (BMD) is a genetic and progressive neuromuscular disease caused by mutations in the dystrophin gene with no available cure. A case report and comprehensive review of BMD cases aim to provide important clues for early diagnosis and implications for clinical practice. Genes and pathways identified from microarray data of muscle samples from patients with BMD help uncover the potential mechanism and provide novel therapeutic targets for dystrophin-deficient muscular dystrophies.

Methods

We describe a BMD family with a 10-year-old boy as the proband and reviewed BMD cases from PubMed. Datasets from the Gene Expression Omnibus database were downloaded and integrated with the online software.

Results

The systematic review revealed the clinical manifestations and mutation points of the dystrophin gene. Gene ontology analysis showed that extracellular matrix organization and extracellular structure organization with enrichment of upregulated genes coexist in three datasets. We present the first report of TUBA1A involvement in the development of BMD/Duchenne muscular dystrophy (DMD).

Discussion

This study provides important implications for clinical practice, uncovering the potential mechanism of the progress of BMD/DMD, and provided new therapeutic targets.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Guo R, Zhu G, Zhu H, Ma R, Peng Y, Liang D et al (2015) DMD mutation spectrum analysis in 613 Chinese patients with dystrophinopathy. J Hum Genet 60:435–442. https://doi.org/10.1038/jhg.2015.43

    Article  CAS  PubMed  Google Scholar 

  2. Sato T, Higashioka K, Sakurai H, Yamamoto T, Goshima N, Ueno M et al (2019) Core transcription factors promote induction of PAX3-positive skeletal muscle stem cells. Stem Cell Rep 13:352–365. https://doi.org/10.1016/j.stemcr.2019.06.006

    Article  CAS  Google Scholar 

  3. Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe L et al (2010) Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol. https://doi.org/10.1016/S1474-4422(09)70271-6

    Article  PubMed  Google Scholar 

  4. El-Aloul B, Altamirano-Diaz L, Zapata-Aldana E, Rodrigues R, Malvankar-Mehta MS, Nguyen CT et al (2017) Pharmacological therapy for the prevention and management of cardiomyopathy in Duchenne muscular dystrophy: a systematic review. Neuromuscul Disord 27:4–14. https://doi.org/10.1016/j.nmd.2016.09.019

    Article  PubMed  Google Scholar 

  5. Mah JK, Korngut L, Dykeman J, Day L, Pringsheim T, Jette N (2014) A systematic review and meta-analysis on the epidemiology of Duchenne and Becker muscular dystrophy. Neuromuscul Disord 24:482–491. https://doi.org/10.1016/j.nmd.2014.03.008

    Article  PubMed  Google Scholar 

  6. Tsoumpra MK, Fukumoto S, Matsumoto T, Takeda S, Wood MJA, Aoki Y. 2019 Peptide-conjugate antisense based splice-correction for Duchenne muscular dystrophy and other neuromuscular diseases. EBiomedicine;45: 630–645. https://doi.org/10.1016/j.ebiom.2019.06.036

  7. Wang DN, Wang ZQ, Yan L, He J, Lin MT, Chen WJ et al (2017) Clinical and mutational characteristics of Duchenne muscular dystrophy patients based on a comprehensive database in South China. Neuromuscul Disord 27:715–722. https://doi.org/10.1016/j.nmd.2017.02.010

    Article  PubMed  Google Scholar 

  8. Bell JM, Shields MD, Watters J, Hamilton A, Beringer T, Elliott M, et al. 2017 Interventions to prevent and treat corticosteroid-induced osteoporosis and prevent osteoporotic fractures in Duchenne muscular dystrophy. Cochrane Database Syst Rev;1: CD010899. https://doi.org/10.1002/14651858.CD010899.pub2

  9. Salmaninejad A, Jafari Abarghan Y, Bozorg Qomi S, Bayat H, Yousefi M, Azhdari S et al (2020) Common therapeutic advances for Duchenne muscular dystrophy (DMD). Int J Neurosci 131(14):370–389. https://doi.org/10.1080/00207454.2020.1740218

    Article  PubMed  Google Scholar 

  10. Acsadi G, Moore SA, Chéron A, Delalande O, Bennett L, Kupsky W et al (2012) Novel mutation in spectrin-like repeat 1 of dystrophin central domain causes protein misfolding and mild Becker muscular dystrophy. J Biol Chem 287:18153–18162. https://doi.org/10.1074/jbc.M111.284521

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Andrikopoulos G, Kourouklis S, Trika C, Tzeis S, Rassias I, Papademetriou C et al (2013) Cardiac resynchronization therapy in Becker muscular dystrophy. Hellenic J Cardiol 54:227–229

    PubMed  Google Scholar 

  12. Banihani R, Baskin B, Halliday W, Kobayashi J, Kawamura A, McAdam L et al (2016) A novel mutation in DMD (c.1079715G.A) causes Becker muscular dystrophy associated with intellectual disability. J Dev Behav Pediatr 37(3):239–244. https://doi.org/10.1097/DBP.0000000000000262

    Article  PubMed  Google Scholar 

  13. Calcaterra V, Malvezzi A, Toglia R, Berardinelli A, Bozzola E, Bozzola M, et al. 2013 Growth hormone deficiency in a patient with Becker muscular dystrophy: a pediatric case report. Case Rep Endocrinol 684249 2013. https://doi.org/10.1155/2013/684249

  14. Cao JQ, Zhang C, Feng SW, Yang J, Li Z, Zhang M et al (2011) Study of dystrophin gene non-deletion/duplication mutations causing Becker muscular dystrophy. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 28:308–312. https://doi.org/10.3760/cma.j.issn.1003-9406.2011.03.016

    Article  CAS  PubMed  Google Scholar 

  15. Chamberlain RC, Smith EC, Campbell MJ (2015) Novel rod domain duplication in dystrophin resulting in X-linked dilated cardiomyopathy. Pediatr Neurol 53:439–441. https://doi.org/10.1016/j.pediatrneurol.2015.07.008

    Article  PubMed  Google Scholar 

  16. Dinopoulos A, Papadopoulou A, Manta P, Kekou K, Kanelopoulos T, Fretzayas A et al (2010) Coinheritance of Noonan syndrome and Becker muscular dystrophy. Neuromuscul Disord 20:61–63. https://doi.org/10.1016/j.nmd.2009.08.008

    Article  PubMed  Google Scholar 

  17. Ferreiro V, Giliberto F, Muñiz GM, Francipane L, Marzese DM, Mampel A et al (2009) Asymptomatic Becker muscular dystrophy in a family with a multiexon deletion. Muscle Nerve 39:239–243. https://doi.org/10.1002/mus.21193

    Article  CAS  PubMed  Google Scholar 

  18. Finsterer J, Stöllberger C, Berger E (2012) Beneficial effect of ivabradine in dilated cardiomyopathy from Becker muscular dystrophy. Herz 37:702–705. https://doi.org/10.1007/s00059-012-3643-8

    Article  CAS  PubMed  Google Scholar 

  19. Flanigan KM, Dunn D, Larsen CA, Medne L, Bönnemann CB, Weiss RB (2011) Becker muscular dystrophy due to an inversion of exons 23 and 24 of the DMD gene. Muscle Nerve 44:822–825. https://doi.org/10.1002/mus.22226

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Fujii K, Minami N, Hayashi Y, Nishino I, Nonaka I, Tanabe Y et al (2009) Homozygous female Becker muscular dystrophy. Am J Med Genet A 149A(5):1052–1055. https://doi.org/10.1002/ajmg.a.32808

    Article  CAS  PubMed  Google Scholar 

  21. Guo X, Dai Y, Cui L, Fang Q (2014) A novel dystrophin deletion mutation in a Becker muscular dystrophy patient with early-onset dilated cardiomyopathy. Can J Cardiol 30(956):e1-956.e3. https://doi.org/10.1016/j.cjca.2014.05.002

    Article  Google Scholar 

  22. Gurvich OL, Tuohy TM, Howard MT, Finkel RS, Medne L, Anderson CB et al (2008) DMD pseudoexon mutations: splicing efficiency, phenotype, and potential therapy. Ann Neurol 63:81–89. https://doi.org/10.1002/ana.21290

    Article  CAS  PubMed  Google Scholar 

  23. Hamzi K, Ben Itto AB, Itri M, Nadifi S (2014) Prenatal diagnosis of BMD in Morocco: evolution and limits. J Mol Neurosci 52:459–460. https://doi.org/10.1007/s12031-013-0106-5

    Article  CAS  PubMed  Google Scholar 

  24. Helderman-van den Enden ATJM, Straathof CSM, Aartsma-Rus A, den Dunnen JT, Verbist BM, Bakker E et al (2010) Becker muscular dystrophy patients with deletions around exon 51; a promising outlook for exon skipping therapy in Duchenne patients. Neuromuscul Disord 20(4):251–254. https://doi.org/10.1016/j.nmd.2010.01.013

    Article  CAS  PubMed  Google Scholar 

  25. Hollander SA, Rizzuto S, Hollander AM, Lin A, Liu E, Murray JM et al (2016) Obesity and premature loss of mobility in two adolescents with Becker muscular dystrophy after heartmate II Implantation. ASAIO J 62(1):e5–e7. https://doi.org/10.1097/MAT.0000000000000292

    Article  PubMed  Google Scholar 

  26. Lee KA, Han SH, Choi JR, Chung JS, Choi YC (2008) Becker muscular dystrophy with r(X) carrying an out-of-frame DMD deletion. Pediatr Neurol 39:129–132. https://doi.org/10.1016/j.pediatrneurol.2008.05.002

    Article  PubMed  Google Scholar 

  27. Lerario A, Colombo I, Milani D, Peverelli L, Villa L, Del Bo R et al (2016) A case report with the peculiar concomitance of 2 different genetic syndromes. Medicene (United States) 95(49):e5567. https://doi.org/10.1097/MD.0000000000005567

    Article  Google Scholar 

  28. Messina MF, Aguennouz M, Arrigo T, Rodolico C, Valenzise M, Musumeci O et al (2008) Novel SHOX gene mutation in a short boy with Becker muscular dystrophy: double trouble in two adjacent genes. Horm Res 69:124–128. https://doi.org/10.1159/000111816

    Article  CAS  PubMed  Google Scholar 

  29. Miao J, Feng JC, Zhu D, Yu XF. 2016 A case report: Becker muscular dystrophy presenting with epilepsy and dysgnosia induced by duplication mutation of dystrophin gene. BMC Neurol;16: 255. https://doi.org/10.1186/s12883-016-0777-y

  30. Nakamura M, Sunagawa O, Hokama R, Tsuchiya H, Miyara T, Taba Y et al (2016) A case of refractory heart failure in Becker muscular dystrophy improved with corticosteroid therapy. Int Heart J 57(5):640–644. https://doi.org/10.1536/ihj.16-044

    Article  PubMed  Google Scholar 

  31. Poole TC, Lim TYJ, Buck J, Kong AS (2010) Perioperative cardiac arrest in a patient with previously undiagnosed Becker’s muscular dystrophy after isoflurane anaesthesia for elective surgery. Br J Anaesth 104:487–489. https://doi.org/10.1093/bja/aeq035

    Article  CAS  PubMed  Google Scholar 

  32. Renard D, Labauge P (2010) Thenar and hypothenar muscle hypertrophy in Becker muscular dystrophy. Neuromuscul Disord 20(4):281. https://doi.org/10.1016/j.nmd.2010.01.004

    Article  PubMed  Google Scholar 

  33. Roque JM, Carvalho VO, Pascoalino LN, Ferreira SA, Bocchi EA, Guimarães GV (2011) Physical training in Becker muscular dystrophy associated with heart failure. Arq Bras Cardiol 97:e128–e131. https://doi.org/10.1590/S0066-782X2011001500016

    Article  PubMed  Google Scholar 

  34. Rudnik-Schöneborn S, Weis J, Kress W, Häusler M, Zerres K (2008) Becker’s muscular dystrophy aggravating facioscapulohumeral muscular dystrophy - double trouble as an explanation for an atypical phenotype. Neuromuscul Disord 18:881–885. https://doi.org/10.1016/j.nmd.2008.06.387

    Article  PubMed  Google Scholar 

  35. Shaboodien G, Watkins DA, Pillay K, Beighton P, Heckmann JM, Mayosi BM (2015) Limb-girdle weakness in a marfanoid man: distinguishing calpainopathy from Becker’s muscular dystrophy. Pract Neurol 15:152–154. https://doi.org/10.1136/practneurol-2014-000992

    Article  PubMed  Google Scholar 

  36. Sharma A, Sane H, Gokulchandra N, Sharan R, Paranjape A, Kulkarni P et al (2016) Effect of cellular therapy in progression of Becker’s muscular dystrophy: a case study. Eur J Transl Myol 26(1):5522. https://doi.org/10.4081/ejtm.2016.5522

    Article  PubMed  PubMed Central  Google Scholar 

  37. Silva Vieira M, Drivas P, Mohiaddin RH (2012) Becker’s muscular dystrophy cardiomyopathy: insights from imaging modalities. Rev Port Cardiol 31:833–834. https://doi.org/10.1016/j.repc.2012.05.011

    Article  PubMed  Google Scholar 

  38. Tramonti C, Rossi B, Chisari C (2016) Extensive functional evaluations to monitor aerobic training in Becker muscular dystrophy: a case report. Eur J Transl Myol 26(2):5873. https://doi.org/10.4081/ejtm.2016.5873

    Article  PubMed  PubMed Central  Google Scholar 

  39. Tsuda T, Fitzgerald K, Scavena M, Gidding S, Cox MO, Marks H et al (2015) Early-progressive dilated cardiomyopathy in a family with Becker muscular dystrophy related to a novel frameshift mutation in the dystrophin gene exon 27. J Hum Genet 60:151–155. https://doi.org/10.1038/jhg.2014.112

    Article  CAS  PubMed  Google Scholar 

  40. Webb ST, Patil V, Vuylsteke A (2007) Anaesthesia for non-cardiac surgery in a patient with Becker’s muscular dystrophy supported with a left ventricular assist device (1). Eur J Anaesthesiol. https://doi.org/10.1017/S0265021507000336

    Article  PubMed  Google Scholar 

  41. Witting N, Duno M, Vissing J (2011) Deletion of exon 26 of the dystrophin gene is associated with a mild Becker muscular dystrophy phenotype. Acta Myol 30:182–184

    CAS  PubMed  PubMed Central  Google Scholar 

  42. Witting N, Duno M, Vissing J (2013) Becker muscular dystrophy with widespread muscle hypertrophy and a non-sense mutation of exon 2. Neuromuscul Disord 23:25–28. https://doi.org/10.1016/j.nmd.2012.07.004

    Article  CAS  PubMed  Google Scholar 

  43. Yilmaz A, Gdynia HJ, Mahrholdt H, Sechtem U (2009) Cardiovascular magnetic resonance reveals similar damage to the heart of patients with Becker and limb-girdle muscular dystrophy but no cardiac symptoms. J Magn Reson Imaging 30:876–877. https://doi.org/10.1002/jmri.21905

    Article  PubMed  Google Scholar 

  44. Rha DW, Park ES, Kim J, Kim SH, Chang WH (2009) Detection of focal cerebral injury using diffusion tensor magnetic resonance imaging in a boy with Becker muscular dystrophy. Neuropediatrics 40:298–300. https://doi.org/10.1055/s-0030-1252050

    Article  PubMed  Google Scholar 

  45. Ionescu CN, Kapoor A, Protopapas Z, Marcu CB (2009) Cardiac assessment of patients with Becker’s muscular dystrophy. Conn Med 73:395–397

    PubMed  Google Scholar 

  46. Haslett JN, Sanoudou D, Kho AT, Bennett RR, Greenberg SA, Kohane IS et al (2002) Gene expression comparison of biopsies from Duchenne muscular dystrophy (DMD) and normal skeletal muscle. Proc Natl Acad Sci U S A 99(23):15000–15005. https://doi.org/10.1073/pnas.192571199

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Haslett JN, Sanoudou D, Kho AT, Han M, Bennett RR, Kohane IS et al (2003) Gene expression profiling of Duchenne muscular dystrophy skeletal muscle. Neurogenetics 4:163–171. https://doi.org/10.1007/s10048-003-0148-x

    Article  CAS  PubMed  Google Scholar 

  48. Pescatori M, Broccolini A, Minetti C, Bertini E, Bruno C, D’Amico A et al (2007) Gene expression profiling in the early phases of DMD: a constant molecular signature characterizes DMD muscle from early postnatal life throughout disease progression. FASEB J 21(4):1210–1226. https://doi.org/10.1096/fj.06-7285com

    Article  CAS  PubMed  Google Scholar 

  49. Barakat-Haddad C, Shin S, Candundo H, Van Lieshout PV, Martino R (2017) A systematic review of risk factors associated with muscular dystrophies. Neurotoxicology 61:55–62. https://doi.org/10.1016/j.neuro.2016.03.007

    Article  CAS  PubMed  Google Scholar 

  50. Aartsma-Rus A, den Dunnen JT (2019) Phenotype predictions for exon deletions/duplications: a user guide for professionals and clinicians using Becker and Duchenne muscular dystrophy as examples. Hum Mutat 40:1–4. https://doi.org/10.1002/humu.23850

    Article  Google Scholar 

  51. Salmaninejad A, Valilou SF, Bayat H, Ebadi N, Daraei A, Yousefi M et al (2018) Duchenne muscular dystrophy: an updated review of common available therapies. Int J Neurosci 128:854–864. https://doi.org/10.1080/00207454.2018.1430694

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We thank the patients for their cooperation. We wish to thank Dr. Xiaoqin Hu, MD, Ph.D., who helped contact the patients.

We are grateful to Professor Cheng Zhang at the Department of Neurology, Affiliated Hospital for Sun-Yat-sen University, China, for the thoughtful discussion and clinical evaluation of patients.

Funding

This work was supported by the National Natural Science Foundation of China grants (No.81550031 and No.81201981), Hubei Provincial Health and Family Planning Commission Key Support Project (No. WJ2017Z025), Hubei Provincial Natural Science Foundation Surface project grant (No.2015CFB197), and Talents Innovation, Entrepreneurship, and Excellence-creating Project grant of Yichang City, Hubei Province.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Liang Yu or Yunhong Zha.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Li, M., Han, Y., Wang, S. et al. Becker muscular dystrophy: case report, review of the literature, and analysis of differentially expressed hub genes. Neurol Sci 43, 243–253 (2022). https://doi.org/10.1007/s10072-021-05499-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-021-05499-2

Keywords

Navigation